COMPLIANCE INFO_2004-2020 - Laserfiche WebLink

Home Browse Search

�=�,� 01� Ue AgencyW Dep8r6Ttent Of Wealttl �,, RAI�IQACTIVE MATERIAL LICENSE License.Number. 5790.39 Amendment Number 8 15. Sealed sources possessed under this license shall be tested for leakage and/or contamination as required by Title 17, California Code of Regulations, Section 30275 (c). 16. Except for alpha sources, the periodic leak test required by Condition 15 does not apply to sealed sources that are stored and not being used. The sources excepted from this test shall be tested for leakage prior to any use or transfer to another person unless they have been leak tested within six months prior to the date of use or transfer. 17. The follo`vina individuals are authorized to collect wipe test samples of sealed sources possessed under this license using leak test kits acceptable to the California Department of Health Services: (a) The Radiation Safety Officer (b) Qualified individuals designated in writing by the Radiation Safety Officer 18. The licensee is authorized to hold radioactive materials with a physical half-life of less than 65 days for deca" in storage before disposal in ordinary trash provided: (a) Radioactive waste to be disposed of in this manner shall be held for decay in storage for at least 10 half-lives. (b) Before disposal as normal waste, radioactive waste shall be surveyed to determine that its radioactivity cannot be distinguished from background. All radiation labels shall be removed or obliterated. 19. The licensee may use any commercially available device, acceptable to?hc 1_ S. Nuclear Ret ulatory Commission,an Agreement State or a Licensing State, for doing linearity tests of its <;ose calibrat,1-: ,r^vias -ne procedures described by the manufacturer of the linearity device are followed. 20. Nuclear medicine technology procedures shall be performed by nuclear medicine technologists pursuant to Title 17, California Code of Regulations, Subchapter 4.6. Such procedures shall be performed under the supervision of authorized user physicians on this license who meet the criteria specified in Section 30510. Certificates or special permits issued pursuant to Subchapter 4.6 shall be prominently displayed at the facility(ies) authorized on this license. 21. Treatment and management of patients receiving therapeutic quantities of unsealed radioactive materials shall be in accordance with guidance contained in Chapter 4, "Release from Hospital of Patients Containing Radioactive Material' National Council on Radiation Protection and Measurements (NCRP) Report No. 37, "Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides" (NCRP Publications, P.O. Box 30175, Washington,D.C. 20014). 22. Production or processing of radiopharmaceuticals for the purpose of commercial distribution to other licensees is not authorized by this license. 23. For a period not to exceed 60 days in any calendar year, a visiting physician is authorized to use licensed materials for human use under the terms of this license,provided the visiting physician: (e) Has the prior written permission of the hospital's Administrator and its Radiation Safety Committee. (f) Is specifically named as a user on a U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State license authorizing human use. (g) Performs only those procedures for which the physician is specifically authorized by the U.S. Nuclear Regulatory Commission,an Agreement State or a Licensing State license.